Axcella Health posts second quarter 2019 net loss of $14.4 million
Initiated a Non-IND, IRB-Approved Clinical Study for AXA1957 in adolescent subjects with NAFLD Announced the publication in Frontiers of data…
Pharmaceuticals, Biotechnology and Life Sciences
Initiated a Non-IND, IRB-Approved Clinical Study for AXA1957 in adolescent subjects with NAFLD Announced the publication in Frontiers of data…
DUARTE, Calif.–(BUSINESS WIRE)–#CityofHope—Saul Priceman, Ph.D., City of Hope assistant professor in the Department of Hematology & Hematopoietic Cell Transplantation, and…
LONDON–(BUSINESS WIRE)–#CompetitiveIntelligence–Infiniti Research, a leading market intelligence solutions provider, has recently announced the completion of their latest market research engagement…
LAVAL, Québec–(BUSINESS WIRE)–#Altasciences—Altasciences is proud to announce that CEO Chris Perkin has been recognized as a 2019 Red Jacket honoree.…
DUBLIN–(BUSINESS WIRE)–The “Autoinjectors – Market Analysis, Trends, and Forecasts” report has been added to ResearchAndMarkets.com’s offering. Autoinjectors market worldwide is…
With strong first half 2019 sales over $30 Million, Innovest Global continues into next phase of growth with the addition…
SCOTTSDALE, Ariz.–(BUSINESS WIRE)–#VirTrial—VirTrial today announced a training and certificate program to help research sites prepare for hybrid clinical trials which…
SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) partner CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing…
LineaRx Positioned to Benefit from Increasing Demand for Nucleic-Acid Dependent Therapies; Potential to Make Redirected Cell Therapies, such as CAR…
BRISBANE, Calif. & ST. LOUIS–(BUSINESS WIRE)–Arch Oncology, Inc., a clinical-stage immuno-oncology company focused on the discovery and development of best-in-class…